Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 1/Phase 2)
Deficiency Diseases (Phase 1/Phase 2)
Epstein-Barr Virus Infections (Phase 1)
Fanconi Anemia (Phase 1/Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
Leukemia (Phase 1)
Lymphoma (Phase 1)
Metabolic Diseases (Phase 1/Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Nasopharyngeal Neoplasms (Phase 1)
Primary Immunodeficiency Diseases (Phase 1/Phase 2)
Wiskott-Aldrich Syndrome (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue